The paradox of escalating immunotherapy for uveal melanoma liver metastases

This publication has 10 references indexed in Scilit:

• Functions and clinical implications of the liver microenvironment in hepatic uveal melanoma metastases
  Cancer and Metastasis Reviews, 2025
• Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis
  Scientific Reports, 2024
• Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial)
  Journal of Clinical Oncology, 2023
• Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
  New England Journal of Medicine, 2021
• Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
  Nature Medicine, 2021
• Locoregional Therapies for the Treatment of Uveal Melanoma Hepatic Metastases
  Seminars in Interventional Radiology, 2020
• Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours
  Nature Communications, 2020
• Uveal melanoma
  Nature Reviews Disease Primers, 2020
• Clinical outcomes in metastatic uveal melanoma treated with PD‐1 and PD‐L1 antibodies
  Cancer, 2016
• Mutations inGNA11in Uveal Melanoma
  New England Journal of Medicine, 2010